Contact

All Stories

  1. Exosomes: Emerging Modulators of Pancreatic Cancer Drug Resistance

    Article • Cancers, September 2023, MDPI AG

    Prof. Antimo Migliaccio

  2. Role of the Androgen Receptor in Gender-Related Cancers

    Article • Endocrines, June 2023, MDPI AG

    Prof. Antimo Migliaccio

  3. The Androgen Regulation of Matrix Metalloproteases in Prostate Cancer and Its Related Tumor Microenvironment

    Article • Endocrines, May 2023, MDPI AG

    Prof. Antimo Migliaccio

  4. The Role of the Androgen Receptor in Skeletal Muscle and Its Utility as a Target for Restoring Muscle Functions

    Article • March 2023, MDPI AG

    Prof. Antimo Migliaccio

  5. The Nerve-Growth Factor Signaling in Gender-Related Cancers

    Article • March 2023, MDPI AG

    Prof. Antimo Migliaccio

  6. New Approaches Targeting the Invasive Phenotype of Prostate Cancer-Associated Fibroblasts

    Article • March 2023, MDPI AG

    Prof. Antimo Migliaccio

  7. Androgens and NGF Mediate the Neurite-Outgrowth through Inactivation of RhoA

    Article • Cells, January 2023, MDPI AG

    Prof. Antimo Migliaccio

  8. Agri-Food By-Products in Cancer: New Targets and Strategies

    Article • Cancers, November 2022, MDPI AG

    Prof. Antimo Migliaccio

  9. Inhibition of Vps34 and p110δ PI3K Impairs Migration, Invasion and Three-Dimensional Spheroid Growth in Breast Cancer Cells

    Article • International Journal of Molecular Sciences, August 2022, MDPI AG

    Prof. Antimo Migliaccio

  10. New TRPM8 blockers exert anticancer activity over castration-resistant prostate cancer models

    Article • European Journal of Medicinal Chemistry, August 2022, Elsevier

    Prof. Antimo Migliaccio

  11. P-272 Estrogen receptors influence the epithelial-to-mesenchymal transition of pancreatic cancer cell lines

    Article • Annals of Oncology, June 2022, Elsevier

    Prof. Antimo Migliaccio

  12. Targeting ERβ to fight melanoma: a new valid approach?

    Article • Journal of Translational Medicine, April 2022, Springer Science + Business Media

    Prof. Antimo Migliaccio

  13. New Insights and Emerging Therapeutic Approaches in Prostate Cancer

    Article • Frontiers in Endocrinology, February 2022, Frontiers

    Prof. Antimo Migliaccio

  14. A Small Peptide Targeting the Ligand-Induced Androgen Receptor/Filamin a Interaction Inhibits the Invasive Phenotype of Prostate Cancer Cells

    Article • Cells, December 2021, MDPI AG

    Prof. Antimo Migliaccio

  15. ERβ in Triple-Negative Breast Cancer: Emerging Concepts and Therapeutic Possibilities

    Article • Endocrines, September 2021, MDPI AG

    Prof. Antimo Migliaccio

  16. Exploiting the mechanism of estrogen-induced transcription to fight breast cancer

    Article • Experimental & Molecular Medicine, July 2021, Springer Science + Business Media

    Prof. Antimo Migliaccio

  17. Correction to: The androgen receptor/filamin A complex as a target in prostate cancer microenvironment

    Article • Cell Death and Disease, March 2021, Springer Science + Business Media

    Prof. Antimo Migliaccio

  18. The androgen receptor/filamin A complex as a target in prostate cancer microenvironment

    Article • Cell Death and Disease, January 2021, Springer Science + Business Media

    Prof. Antimo Migliaccio

  19. Role of the demethylase LSD-1 in cell functions

    Article • Experimental & Molecular Medicine, December 2020, Springer Science + Business Media

    Prof. Antimo Migliaccio

  20. Acetylation/methylation at lysine 9 in histone H3 as a mark of nucleosome asymmetry in human somatic breast cells

    Article • Cell Death Discovery, May 2020, Springer Science + Business Media

    Prof. Antimo Migliaccio

  21. Role of ROS generated by nuclear protein modification in the development of cancer

    Article • Experimental & Molecular Medicine, February 2020, Springer Science + Business Media

    Prof. Antimo Migliaccio

  22. Breast cancer stem cells: the role of sex steroid receptors

    Article • World Journal of Stem Cells, September 2019, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Prof. Antimo Migliaccio

  23. Estrogen Receptors in Epithelial-Mesenchymal Transition of Prostate Cancer

    Article • Cancers, September 2019, MDPI AG

    Prof. Antimo Migliaccio

  24. Nerve Growth Factor Induces Proliferation and Aggressiveness in Prostate Cancer Cells

    Article • Cancers, June 2019, MDPI AG

    Prof. Antimo Migliaccio

  25. BRD9 binds cell type-specific chromatin regions regulating leukemic cell survival via STAT5 inhibition

    Article • Cell Death and Disease, April 2019, Springer Science + Business Media

    Prof. Antimo Migliaccio

  26. NGF Induces Proliferation and Aggressiveness In Prostate Cancer Cells.

    Article • April 2019, MDPI AG

    Prof. Antimo Migliaccio

  27. Androgens Induce Invasiveness of Triple Negative Breast Cancer Cells Through AR/Src/PI3-K Complex Assembly

    Article • Scientific Reports, March 2019, Springer Science + Business Media

    Prof. Antimo Migliaccio

  28. Estrogens Modulate Somatostatin Receptors Expression and Synergize With the Somatostatin Analog Pasireotide in Prostate Cells

    Article • Frontiers in Pharmacology, February 2019, Frontiers

    Prof. Antimo Migliaccio

  29. The Androgen Receptor in Breast Cancer

    Article • Frontiers in Endocrinology, August 2018, Frontiers

    Prof. Antimo Migliaccio

  30. The HDAC inhibitor SAHA regulates CBX2 stability via a SUMO-triggered ubiquitin-mediated pathway in leukemia

    Article • Oncogene, February 2018, Springer Science + Business Media

    Prof. Antimo Migliaccio

  31. Cross-talk between androgen receptor and nerve growth factor receptor in prostate cancer cells: implications for a new therapeutic approach

    Article • Cell Death Discovery, January 2018, Springer Science + Business Media

    Prof. Antimo Migliaccio

  32. Bisphenol A induces cell cycle arrest in primary and prostate cancer cells through EGFR/ERK/p53 signaling pathway activation

    Article • Oncotarget, December 2017, Impact Journals, LLC

    Prof. Antimo Migliaccio

  33. Inhibition of p110δ PI3K prevents inflammatory response and restenosis after artery injury

    Article • Bioscience Reports, August 2017, Portland Press Ltd.

    Prof. Antimo Migliaccio

  34. Extranuclear partners of androgen receptor: at the crossroads of proliferation, migration, and neuritogenesis

    Article • The FASEB Journal, April 2017, Federation of American Societies For Experimental Biology (FASEB)

    Prof Gabriella Castoria, Prof. Antimo Migliaccio, Ferdinando Auricchio

  35. Recent advances on bisphenol-A and endocrine disruptor effects on human prostate cancer

    Article • Molecular and Cellular Endocrinology, February 2017, Elsevier

    Prof Gabriella Castoria, Prof. Antimo Migliaccio

  36. Faculty of 1000 evaluation for Progesterone receptor modulates ERα action in breast cancer.

    Article • May 2016, Faculty of 1000, Ltd.

    Prof. Antimo Migliaccio

  37. Estradiol and Estrogen Receptor Agonists Oppose Oncogenic Actions of Leptin in HepG2 Cells

    Article • PLoS ONE, March 2016, PLOS

    Prof. Antimo Migliaccio

  38. Cross-talk between androgen receptor/filamin A and TrkA regulates neurite outgrowth in PC12 cells

    Article • Molecular Biology of the Cell, August 2015, American Society for Cell Biology (ASCB)

    Prof. Antimo Migliaccio

  39. Role of JMJD6 in Breast Tumourigenesis

    Article • PLoS ONE, May 2015, PLOS

    Prof. Antimo Migliaccio

  40. Non-Genomic Androgen Action Regulates Proliferative/Migratory Signaling in Stromal Cells

    Article • Frontiers in Endocrinology, January 2015, Frontiers

    Prof Gabriella Castoria, Prof. Antimo Migliaccio

  41. Faculty of 1000 evaluation for LYN-activating mutations mediate antiestrogen resistance in estrogen receptor-positive breast cancer.

    Article • December 2014, Faculty of 1000, Ltd.

    Prof. Antimo Migliaccio

  42. Role of non-genomic androgen signalling in suppressing proliferation of fibroblasts and fibrosarcoma cells

    Article • Cell Death and Disease, December 2014, Springer Science + Business Media

    Prof. Antimo Migliaccio

  43. Nuclear receptor-induced transcription is driven by spatially and timely restricted waves of ROS

    Article • Nucleus, August 2014, Taylor & Francis

    Prof Gabriella Castoria, Prof. Antimo Migliaccio

  44. Expression of Autophagy-Related Proteins According to Androgen Receptor and HER-2 Status in Estrogen Receptor-Negative Breast Cancer

    Article • PLoS ONE, August 2014, PLOS

    Prof. Antimo Migliaccio

  45. Extremely Low-Frequency Electromagnetic Fields Cause G1 Phase Arrest through the Activation of the ATM-Chk2-p21 Pathway

    Article • PLoS ONE, August 2014, PLOS

    Prof. Antimo Migliaccio

  46. Epigenetic drugs against cancer: an evolving landscape

    Article • Archives of Toxicology, August 2014, Springer Science + Business Media

    Prof. Antimo Migliaccio

  47. Phosphorylation of H3 serine 10 by IKKα governs cyclical production of ROS in estrogen-induced transcription and ensures DNA wholeness

    Article • Cell Death and Differentiation, June 2014, Springer Science + Business Media

    Prof. Antimo Migliaccio

  48. A Firmer Understanding of the Effect of Hypergravity on Thyroid Tissue: Cholesterol and Thyrotropin Receptor

    Article • PLoS ONE, May 2014, PLOS

    Prof. Antimo Migliaccio

  49. Diversin Is Overexpressed in Breast Cancer and Accelerates Cell Proliferation and Invasion

    Article • PLoS ONE, May 2014, PLOS

    Prof. Antimo Migliaccio

  50. The Deficiency of Tumor Suppressor Prep1 Accelerates the Onset of Meis1- Hoxa9 Leukemogenesis

    Article • PLoS ONE, May 2014, PLOS

    Prof. Antimo Migliaccio

  51. Dissection of Estrogen Receptor Alpha Signaling Pathways in Osteoblasts Using RNA-Sequencing

    Article • PLoS ONE, April 2014, PLOS

    Prof. Antimo Migliaccio

  52. Metformin Inhibits Androgen-Induced IGF-IR Up-Regulation in Prostate Cancer Cells by Disrupting Membrane-Initiated Androgen Signaling

    Article • Endocrinology, April 2014, Endocrine Society

    Prof. Antimo Migliaccio

  53. Analysis of Histone Posttranslational Modifications in the Control of Chromatin Plasticity Observed at Estrogen-Responsive Sites in Human Breast Cancer Cells

    Article • January 2014, Springer Science + Business Media

    Prof. Antimo Migliaccio

  54. Phosphoinositide 3-Kinase Assay in Breast Cancer Cell Extracts

    Article • January 2014, Springer Science + Business Media

    Prof. Antimo Migliaccio

  55. Resveratrol Couples Apoptosis with Autophagy in UVB-Irradiated HaCaT Cells

    Article • PLoS ONE, November 2013, PLOS

    Prof. Antimo Migliaccio

  56. Nuclear Ras2-GTP Controls Invasive Growth in Saccharomyces cerevisiae

    Article • PLoS ONE, November 2013, PLOS

    Prof. Antimo Migliaccio

  57. Protein-Tyrosine Phosphatase H1 Increases Breast Cancer Sensitivity to Antiestrogens by Dephosphorylating Estrogen Receptor at Tyr537

    Article • Molecular Cancer Therapeutics, November 2013, American Association for Cancer Research (AACR)

    Prof. Antimo Migliaccio

  58. RTK/ERK Pathway under Natural Selection Associated with Prostate Cancer

    Article • PLoS ONE, November 2013, PLOS

    Prof. Antimo Migliaccio

  59. Targeting Androgen Receptor/Src Complex Impairs the Aggressive Phenotype of Human Fibrosarcoma Cells

    Article • PLoS ONE, October 2013, PLOS

    Prof Gabriella Castoria, Prof. Antimo Migliaccio

  60. Correction: TACC3 Is Essential for EGF-Mediated EMT in Cervical Cancer

    Article • PLoS ONE, September 2013, PLOS

    Prof. Antimo Migliaccio

  61. Estradiol and Tamoxifen Induce Cell Migration through GPR30 and Activation of Focal Adhesion Kinase (FAK) in Endometrial Cancers with Low or without Nuclear Estrogen Receptor α (ERα)

    Article • PLoS ONE, September 2013, PLOS

    Prof. Antimo Migliaccio

  62. Differentially Expressed Androgen-Regulated Genes in Androgen-Sensitive Tissues Reveal Potential Biomarkers of Early Prostate Cancer

    Article • PLoS ONE, June 2013, PLOS

    Prof. Antimo Migliaccio

  63. Faculty of 1000 evaluation for FBXL2- and PTPL1-mediated degradation of p110-free p85β regulatory subunit controls the PI(3)K signalling cascade.

    Article • June 2013, Faculty of 1000, Ltd.

    Prof. Antimo Migliaccio

  64. Faculty of 1000 evaluation for Activation of mitogen- and stress-activated kinase 1 is required for proliferation of breast cancer cells in response to estrogens or progestins.

    Article • June 2013, Faculty of 1000, Ltd.

    Prof. Antimo Migliaccio

  65. Retinoic acid impairs estrogen signaling in breast cancer cells by interfering with activation of LSD1 via PKA

    Article • Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, May 2013, Elsevier

    Prof. Antimo Migliaccio

  66. Acetylcholine Acts on Androgen Receptor to Promote the Migration and Invasion but Inhibit the Apoptosis of Human Hepatocarcinoma

    Article • PLoS ONE, April 2013, PLOS

    Prof. Antimo Migliaccio

  67. Does Changing Androgen Receptor Status during Prostate Cancer Development Impact upon Cholesterol Homeostasis?

    Article • PLoS ONE, January 2013, PLOS

    Prof. Antimo Migliaccio

  68. Estradiol Receptor (ER) Chromatin Immunoprecipitation in MCF-7 Cells

    Article • BIO-PROTOCOL, January 2013, Bio-Protocol, LLC

    Prof Gabriella Castoria, Prof. Antimo Migliaccio

  69. p130Cas Over-Expression Impairs Mammary Branching Morphogenesis in Response to Estrogen and EGF

    Article • PLoS ONE, December 2012, PLOS

    Prof. Antimo Migliaccio

  70. Faculty of 1000 evaluation for Estrogen receptor alpha mediates progestin-induced mammary tumor growth by interacting with progesterone receptors at the cyclin D1/MYC promoters.

    Article • October 2012, Faculty of 1000, Ltd.

    Prof. Antimo Migliaccio

  71. The DEK Oncogene Is a Target of Steroid Hormone Receptor Signaling in Breast Cancer

    Article • PLoS ONE, October 2012, PLOS

    Prof. Antimo Migliaccio

  72. A Switch Role of Src in the Biphasic EGF Signaling of ER-Negative Breast Cancer Cells

    Article • PLoS ONE, August 2012, PLOS

    Prof. Antimo Migliaccio

  73. Polyproline and Tat transduction peptides in the study of the rapid actions of steroid receptors

    Article • Steroids, August 2012, Elsevier

    Prof Gabriella Castoria, Prof. Antimo Migliaccio

  74. Neuregulin Promotes Incomplete Autophagy of Prostate Cancer Cells That Is Independent of mTOR Pathway Inhibition

    Article • PLoS ONE, May 2012, PLOS

    Prof. Antimo Migliaccio

  75. Nuclear Factor-Kappa B Inhibition Can Enhance Apoptosis of Differentiated Thyroid Cancer Cells Induced by 131I

    Article • PLoS ONE, March 2012, PLOS

    Prof. Antimo Migliaccio

  76. ALK-Activating Homologous Mutations in LTK Induce Cellular Transformation

    Article • PLoS ONE, February 2012, PLOS

    Prof. Antimo Migliaccio

  77. Faculty of 1000 evaluation for Estrogen receptor β exerts tumor repressive functions in human malignant pleural mesothelioma via EGFR inactivation and affects response to gefitinib.

    Article • February 2012, Faculty of 1000, Ltd.

    Prof. Antimo Migliaccio

  78. Faculty of 1000 evaluation for Differential oestrogen receptor binding is associated with clinical outcome in breast cancer.

    Article • January 2012, Faculty of 1000, Ltd.

    Prof. Antimo Migliaccio

  79. Tyrosine phosphorylation of estradiol receptor by Src regulates its hormone-dependent nuclear export and cell cycle progression in breast cancer cells

    Article • Oncogene, January 2012, Springer Science + Business Media

    Prof. Antimo Migliaccio

  80. Advances in Rapid Sex-Steroid Action

    Article • January 2012, Springer Science + Business Media

    Prof Gabriella Castoria, Prof. Antimo Migliaccio

  81. Non-genomic Action of Steroid Hormones: More Questions than Answers

    Article • December 2011, Springer Science + Business Media

    Prof Gabriella Castoria, Prof. Antimo Migliaccio

  82. Faculty of 1000 evaluation for Estrogen regulates tumor growth through a nonclassical pathway that includes the transcription factors ERβ and KLF5.

    Article • April 2011, Faculty of 1000, Ltd.

    Prof. Antimo Migliaccio

  83. Androgen-Induced Cell Migration: Role of Androgen Receptor/Filamin A Association

    Article • PLoS ONE, February 2011, PLOS

    Prof Gabriella Castoria, Prof. Antimo Migliaccio

  84. Analysis of Androgen Receptor Rapid Actions in Cellular Signaling Pathways: Receptor/Src Association

    Article • January 2011, Springer Science + Business Media

    Prof Gabriella Castoria, Prof. Antimo Migliaccio

  85. Targeting rapid action of sex steroid receptors in breast and prostate cancers

    Article • Frontiers in Bioscience, January 2011, Frontiers in Bioscience

    Prof. Antimo Migliaccio

  86. Steroid signaling activation and intracellular localization of sex steroid receptors

    Article • Journal of Cell Communication and Signaling, November 2010, Springer Science + Business Media

    Prof Gabriella Castoria, Prof. Antimo Migliaccio

  87. Cross talk between epidermal growth factor (EGF) receptor and extra nuclear steroid receptors in cell lines

    Article • Molecular and Cellular Endocrinology, October 2010, Elsevier

    Prof Gabriella Castoria, Prof. Antimo Migliaccio

  88. Faculty of 1000 evaluation for c-Abl regulates estrogen receptor alpha transcription activity through its stabilization by phosphorylation.

    Article • October 2010, Faculty of 1000, Ltd.

    Prof. Antimo Migliaccio

  89. Cell proliferation regulated by estradiol receptor: Therapeutic implications

    Article • Steroids, August 2010, Elsevier

    Prof Gabriella Castoria, Prof. Antimo Migliaccio

  90. Faculty of 1000 evaluation for miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis.

    Article • May 2010, Faculty of 1000, Ltd.

    Prof. Antimo Migliaccio

  91. Prostate cancer stem cells: the role of androgen and estrogen receptors

    Article • Oncotarget, May 2010, Impact Journals, LLC

    Prof Gabriella Castoria, Prof. Antimo Migliaccio

  92. Non-Genomic Action of Sex Steroid Hormones

    Article • January 2010, Springer Science + Business Media

    Prof Gabriella Castoria, Prof. Antimo Migliaccio

  93. Signaling-dependent nuclear export of estradiol receptor controls cell cycle progression in breast cancer cells

    Article • Molecular and Cellular Endocrinology, September 2009, Elsevier

    Prof Gabriella Castoria, Prof. Antimo Migliaccio

  94. Faculty of 1000 evaluation for A naturally occurring HER2 carboxy-terminal fragment promotes mammary tumor growth and metastasis.

    Article • August 2009, Faculty of 1000, Ltd.

    Prof. Antimo Migliaccio

  95. Faculty of 1000 evaluation for Tumours with PI3K activation are resistant to dietary restriction.

    Article • March 2009, Faculty of 1000, Ltd.

    Prof. Antimo Migliaccio

  96. Sex-steroid hormones and EGF signalling in breast and prostate cancer cells: Targeting the association of Src with steroid receptors

    Article • Steroids, October 2008, Elsevier

    Prof Gabriella Castoria, Prof. Antimo Migliaccio

  97. Hormone-dependent nuclear export of estradiol receptor and DNA synthesis in breast cancer cells

    Article • The Journal of Cell Biology, July 2008, Rockefeller University Press

    Prof Gabriella Castoria, Prof. Antimo Migliaccio

  98. Integrating signals between cAMP and MAPK pathways in breast cancer

    Article • Frontiers in Bioscience, January 2008, Frontiers in Bioscience

    Prof Gabriella Castoria, Prof. Antimo Migliaccio

  99. Inhibition of Estradiol Receptor/Src Association and Cell Growth by an Estradiol Receptor   Tyrosine-Phosphorylated Peptide

    Article • Molecular Cancer Research, November 2007, American Association for Cancer Research (AACR)

    Prof. Antimo Migliaccio

  100. Src-dependent signalling pathway regulation by sex-steroid hormones: Therapeutic implications

    Article • The International Journal of Biochemistry & Cell Biology, July 2007, Elsevier

    Prof Gabriella Castoria, Prof. Antimo Migliaccio

  101. Inhibition of the SH3 domain-mediated binding of Src to the androgen receptor and its effect on tumor growth

    Article • Oncogene, May 2007, Springer Science + Business Media

    Prof. Antimo Migliaccio

  102. Crosstalk between EGFR and Extranuclear Steroid Receptors

    Article • November 2006, Wiley

    Prof. Antimo Migliaccio

  103. p85 regulatory subunit of PI3K mediates cAMP–PKA and estrogens biological effects on growth and survival

    Article • Oncogene, October 2006, Springer Science + Business Media

    Prof. Antimo Migliaccio

  104. Steroid Receptor Regulation of Epidermal Growth Factor Signaling through Src in Breast and Prostate Cancer Cells: Steroid Antagonist Action

    Article • Cancer Research, November 2005, American Association for Cancer Research (AACR)

    Prof. Antimo Migliaccio

  105. Role of Atypical Protein Kinase C in Estradiol-Triggered G1/S Progression of MCF-7 Cells

    Article • Molecular and Cellular Biology, September 2004, ASM Journals

    Prof. Antimo Migliaccio

  106. Rapid signalling pathway activation by androgens in epithelial and stromal cells

    Article • Steroids, August 2004, Elsevier

    Prof Gabriella Castoria, Prof. Antimo Migliaccio

  107. Androgen-stimulated DNA synthesis and cytoskeletal changes in fibroblasts by a nontranscriptional receptor action

    Article • The Journal of Cell Biology, May 2003, Rockefeller University Press

    Prof Gabriella Castoria, Prof. Antimo Migliaccio

  108. Two Domains of the Progesterone Receptor Interact with the Estrogen Receptor and Are Required for Progesterone Activation of the c-Src/Erk Pathway in Mammalian Cells

    Article • Molecular and Cellular Biology, March 2003, ASM Journals

    Prof. Antimo Migliaccio

  109. Interactions of Estrogen Receptors with Signal Cascade Molecules

    Article • January 2003, Springer Science + Business Media

    Prof Gabriella Castoria, Prof. Antimo Migliaccio

  110. Sex steroid hormones act as growth factors

    Article • The Journal of Steroid Biochemistry and Molecular Biology, December 2002, Elsevier

    Prof. Antimo Migliaccio

  111. PI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cells

    Article • The EMBO Journal, November 2001, Wiley

    Prof Gabriella Castoria, Prof. Antimo Migliaccio

  112. cAMP signaling selectively influences Ras effectors pathways

    Article • Oncogene, March 2001, Springer Science + Business Media

    Professor Antimo Di Maro, Prof. Antimo Migliaccio

  113. Non-transcriptional action of oestradiol and progestin triggers DNA synthesis

    Article • The EMBO Journal, May 1999, Wiley

    Prof Gabriella Castoria, Prof. Antimo Migliaccio

  114. Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor

    Article • The EMBO Journal, April 1998, Wiley

    Prof Gabriella Castoria, Prof. Antimo Migliaccio

  115. Protein Tyrosine Phosphorylation and Estradiol Action

    Article • Annals of the New York Academy of Sciences, April 1996, Wiley

    Prof. Antimo Migliaccio

  116. A 67 kDa non-hormone binding estradiol receptor is present in human mammary cancers

    Article • International Journal of Cancer, March 1996, Wiley

    Prof. Antimo Migliaccio

  117. Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells.

    Article • The EMBO Journal, March 1996, Wiley

    Prof. Antimo Migliaccio

  118. Epidermal growth factor induces protein tyrosine phosphorylation and association of p190 with ras-GTP-ase activating protein in Caco-2 cells

    Article • FEBS Letters, October 1994, Wiley

    Prof Gabriella Castoria, Prof. Antimo Migliaccio

  119. Properties of a purified estradiol-dependent calf uterus tyrosine kinase

    Article • Biochemistry, February 1993, American Chemical Society (ACS)

    Prof Gabriella Castoria, Prof. Antimo Migliaccio

  120. Phosphorylation and estradiol binding of estrogen receptor in hormone-dependent and hormone-independent GR mouse mammary tumors

    Article • International Journal of Cancer, July 1992, Wiley

    Prof Gabriella Castoria, Prof. Antimo Migliaccio

  121. In vitro phosphorylation and hormone binding activation of the synthetic wild type human estradiol receptor

    Article • The Journal of Steroid Biochemistry and Molecular Biology, April 1991, Elsevier

    Prof. Antimo Migliaccio

  122. Serine phosphorylation of biosynthetic pro-urokinase from human tumor cells

    Article • FEBS Letters, June 1990, Wiley

    Prof. Antimo Migliaccio

  123. Phosphorylation on Tyrosine ofin VitroSynthesized Human Estrogen Receptor Activates Its Hormone Binding

    Article • Molecular Endocrinology, July 1989, Endocrine Society

    Prof. Antimo Migliaccio

  124. In VitroInteraction of Estradiol Receptor with Ca2+-Calmodulin

    Article • Molecular Endocrinology, February 1988, Endocrine Society

    Prof Gabriella Castoria, Prof. Antimo Migliaccio

  125. [54] Calmodulin-stimulated estradiol receptor-tyrosine kinase I

    Article • January 1987, Elsevier

    Prof Gabriella Castoria, Prof. Antimo Migliaccio

  126. Phosphorylation on tyrosine of oestradiol-17β receptor in uterus and interaction of oestradiol-17β and glucocorticoid receptors with antiphosphotyrosine antibodies

    Article • Journal of Steroid Biochemistry, January 1987, Elsevier

    Prof. Antimo Migliaccio

  127. Hormone regulation of 17β-estradiol receptor phosphorylation on tyrosine

    Article • March 1986, Wiley

    Prof. Antimo Migliaccio

  128. Activation-inactivation of hormone binding sites of the oestradiol-17β receptor is a multiregulated process

    Article • Journal of Steroid Biochemistry, January 1986, Elsevier

    Prof Gabriella Castoria, Prof. Antimo Migliaccio

  129. Hypnosis for upper gastrointestinal endoscopy

    Article • Gastrointestinal Endoscopy, June 1985, Elsevier

    Prof. Antimo Migliaccio

  130. Direct evidence of in vitro phosphorylation-dephosphorylation of the estradiol-17β receptor. role of Ca2+-Calmodulin in the activation of hormone binding sites

    Article • Journal of Steroid Biochemistry, January 1984, Elsevier

    Prof Gabriella Castoria, Prof. Antimo Migliaccio

  131. Phosphorylation-Dephosphorylation of the Estradiol Receptor Regulates its Hormone Binding Activity

    Article • January 1984, Springer Science + Business Media

    Prof Gabriella Castoria, Prof. Antimo Migliaccio

  132. Phosphorylation of calf uterus 17β-estradiol receptor by endogenous Ca2+-stimulated kinase activating the hormone binding of the receptor

    Article • December 1982, Elsevier

    Prof. Antimo Migliaccio

  133. Evidence that invivo estradiol receptor translocated into nuclei is dephosphorylated and released into cytoplasm

    Article • May 1982, Elsevier

    Prof. Antimo Migliaccio

  134. Hormone binding of estradiol-17β receptor: Evidence for its regulation by cytoplasmic phosphorylation and nuclear dephosphorylation. Prevention of dephosphorylation by antiestrogens

    Article • Journal of Steroid Biochemistry, December 1981, Elsevier

    Prof. Antimo Migliaccio

  135. ATP-dependent enzyme activating hormone binding of estradiol receptor

    Article • Biochemical and Biophysical Research Communications, August 1981, Elsevier

    Prof Gabriella Castoria, Prof. Antimo Migliaccio

  136. In vitro inactivation of oestrogen receptor by nuclei

    Article • FEBS Letters, August 1980, Wiley

    Prof. Antimo Migliaccio

  137. PHOSPHORYLATION ON TYROSINE OF THE 173-ESTRADIOL RECEPTOR

    Article • De Gruyter

    Prof Gabriella Castoria, Prof. Antimo Migliaccio